ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Radiation Oncologists Form New College To Address Identity

April 12, 1991

AACR Unanimously Backs Tough Antismoking Measure

May 18, 1984

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

October 14, 2005

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

September 26, 2003

Annual Report Finds Decreases In Overall Cancer Rates

December 11, 2009

Prevention Clinical Trials Heads Greenwalk Priority Lists For ‘86

February 8, 1985